Ecdysterone
Also known as: 20-Hydroxyecdysone, Beta-Ecdysterone, Ecdy
Phytoecdysteroid | Natural Anabolic & Performance Enhancer
Overview
Ecdysterone (20-Hydroxyecdysone) is a naturally occurring phytoecdysteroid -- a class of steroid hormones that regulate molting and metamorphosis in insects and crustaceans. Despite its name and steroidal structure, ecdysterone does not interact with the androgen receptor and operates through an entirely different mechanism than anabolic-androgenic steroids. It is found in meaningful concentrations in common foods such as spinach (Spinacia oleracea), quinoa (Chenopodium quinoa), and various other plants. Ecdysterone gained significant attention in the strength and performance community following a 2019 study from Freie Universitat Berlin, which demonstrated that trained individuals supplementing with ecdysterone experienced significantly greater muscle mass gains compared to placebo over a 10-week resistance training program. The effect sizes were large enough that the study authors themselves recommended the World Anti-Doping Agency (WADA) consider adding ecdysterone to the prohibited substances list. Unlike traditional anabolic agents, ecdysterone does not cause hormonal suppression, does not require post-cycle therapy, and carries an exceptionally mild side effect profile. Its mechanism appears to involve signaling through estrogen receptor beta (ERbeta), which activates anabolic pathways in skeletal muscle without the androgenic, estrogenic, or hepatotoxic effects associated with traditional performance-enhancing compounds. An injectable form has gained popularity among advanced users seeking higher bioavailability, as oral ecdysterone suffers from significant first-pass metabolism.
Key benefits
- Activation of muscle protein synthesis through ERbeta/PI3K/Akt/mTOR signaling without androgen receptor binding
- Statistically significant increases in lean muscle mass demonstrated in a controlled human trial in trained subjects
- No hormonal suppression -- does not affect testosterone, LH, or FSH levels, eliminating the need for post-cycle therapy
- No androgenic side effects (no hair loss, acne, prostate issues, or virilization in women)
- No hepatotoxicity, unlike oral anabolic steroids that undergo 17-alpha alkylation
- Naturally occurring in common foods (spinach, quinoa), with a long history of safe dietary exposure
- Compatible with other performance compounds due to its non-hormonal mechanism
- Available as a dietary supplement without prescription in most jurisdictions
Mechanism of action
Ecdysterone's anabolic mechanism is fundamentally distinct from that of anabolic-androgenic steroids. Rather than binding to the androgen receptor, ecdysterone exerts its effects primarily through estrogen receptor beta (ERbeta) signaling. ERbeta is expressed in skeletal muscle tissue, and its activation triggers downstream anabolic signaling cascades including the PI3K/Akt pathway, which promotes muscle protein synthesis and inhibits protein degradation. This pathway converges on mTOR (mechanistic target of rapamycin), a master regulator of muscle hypertrophy, leading to increased translation of muscle-specific proteins. Importantly, ecdysterone does not activate estrogen receptor alpha (ERalpha), which is responsible for the feminizing effects of estrogens, nor does it bind to the androgen receptor, glucocorticoid receptor, or mineralocorticoid receptor. This selectivity explains why ecdysterone does not produce the hormonal side effects associated with anabolic steroids -- there is no testosterone suppression, no testicular atrophy, no gynecomastia, no liver toxicity, and no virilization in women. Additional proposed mechanisms include enhanced nitrogen retention in muscle tissue, improved calcium handling in muscle fibers leading to better contractile efficiency, and mild anti-inflammatory effects that may support recovery from exercise-induced muscle damage. Some in vitro studies also suggest ecdysterone may increase satellite cell proliferation, which could contribute to long-term muscle growth capacity.
Molecular data
- Type
- Ecdysteroid (C27H44O7)
- Half-life
- ~4-9 hours
Indications
What the research community uses this compound for, with self-reported effectiveness.
Muscle Growth & Performance
Body Composition
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 500-1000 mg/day | Split into 2 doses (morning and evening) | — |
Delivery method
| Protocol | Dose | Frequency | Duration |
|---|---|---|---|
| — | 50-100 mg/day | Once daily | — |
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Mild gastrointestinal discomfort (nausea, bloating, or stomach upset) with oral doses, particularly at higher dosages taken without food
- Injection site pain, redness, or mild swelling with injectable administration
Rare side effects
- Headache (infrequently reported, unclear if causally related)
- Mild insomnia when taken late in the evening (rarely reported)
- Allergic reaction in individuals with sensitivity to spinach or related plants (for spinach-derived extracts)
Contraindications
- Known allergy to ecdysteroids or spinach-derived compounds
- Pregnancy and breastfeeding (insufficient safety data)
- Individuals with estrogen-sensitive conditions should consult a physician, though ERbeta activation is generally considered protective rather than proliferative
Monitoring
- Body composition measurements (DEXA scan or body fat calipers) at baseline and end of cycle to objectively assess results
- Standard blood panel including liver enzymes (ALT, AST) and lipid profile at baseline and end of cycle as a general safety measure
- Hormone panel (testosterone, LH, FSH, estradiol) to confirm the absence of suppression -- this serves as a quality control check to ensure the product is not contaminated with actual anabolic steroids
- Blood pressure monitoring, particularly with injectable use
References
Primary literature and clinical-trial data informing this entry.